Patents Issued in July 21, 2016
  • Publication number: 20160206512
    Abstract: Various systems and methods for the pressure-regulated transfer of medical fluids are disclosed. The system can include an adapter assembly that connects with a medical container and with a syringe assembly. The syringe assembly can include a first reservoir and a second reservoir. In various embodiments, when the adapter assembly and the syringe assembly are coupled, the first reservoir and the container can exchange regulating fluid and the second reservoir and the container can exchange medical liquid from the medical container.
    Type: Application
    Filed: January 15, 2016
    Publication date: July 21, 2016
    Inventors: Bhupinder Chhikara, Srinath Lingutla, Brandon Eads
  • Publication number: 20160206513
    Abstract: The present invention relates to mass production of micro-containers containing an active ingredient and methods for manufacturing micro-containers containing an active ingredient.
    Type: Application
    Filed: September 1, 2014
    Publication date: July 21, 2016
    Inventors: Johan NAGSTRUP, Stephan Sylvest KELLER, Anja BOISEN, Ritika Singh PETERSEN
  • Publication number: 20160206514
    Abstract: A system and method for measuring medication includes providing a graphical user interface (GUI) including a representation of a medication or a medication container. An indication to measure at least one dimension of the medication or the medication container is provided in the GUI. At least one signal including at least one measured dimension of the medication or the medication container is received by one or more processors that process and store the at least one measured dimension. The at least one measured dimension is provided in the GUI in association with the indication to measure the at least one dimension of the medication or the medication container.
    Type: Application
    Filed: January 19, 2015
    Publication date: July 21, 2016
    Inventors: Robert Eckert, Kirk Young
  • Publication number: 20160206515
    Abstract: A system and device for feeding infants and babies semi-solid foods while limiting messes may include a hollow food chamber that can be filled with food using a plunger and a suction loading tube attachment. The suction loading tube attachment may remain in the baby food container to limit spills. The baby then sucks the food from the hollow food chamber through a nipple that is generally over-sized with an enlarged nipple opening.
    Type: Application
    Filed: January 17, 2015
    Publication date: July 21, 2016
    Inventor: Hal Snarr
  • Publication number: 20160206516
    Abstract: A double male connector (1) includes a first male luer (10) on one end and a second male luer (20) on the other end. The first male luer (10) and the second male luer (20) are in communication with each other. An outer circumferential surface of the first male luer (10) constitutes a first tapered surface (12) whose outer diameter decreases toward a leading end of the first male luer, and an outer circumferential surface of the second male luer (20) constitutes a second tapered surface (22) whose outer diameter decreases toward a leading end of the second male luer. A tubular portion (15) surrounds the first male luer (10). A female screw (16) is formed on an inner circumferential surface of the tubular portion (15).
    Type: Application
    Filed: September 5, 2014
    Publication date: July 21, 2016
    Inventors: Takahiko KUNISHIGE, Yasumasa UEHARA, Asami UEDA, Takayuki UEDA, Yutaka UEDA, Kazuhiko TAKIMOTO, Koichiro TOYOTA, Megumi UEHARA
  • Publication number: 20160206517
    Abstract: Disclosed is an NGT system, the system comprises a nasogastric tube having a diameter and length configured to pass through an esophagus such that the lumen of the NGT maintains fluid communication with a portion of the digestive tract, and a digestive tract sensor operatively associated with the NGT, the digestive tract sensor configured to sense from inside the body and transmit signals in response to one or both of conditions relating to nourishment states of the digestive tract, and positioning of the NGT.
    Type: Application
    Filed: March 27, 2016
    Publication date: July 21, 2016
    Applicant: ART Healthcare Ltd.
    Inventor: Liron ELIA
  • Publication number: 20160206518
    Abstract: A pacifier comprising a guard, having a first surface and an opposing second surface, the second surface having a threaded connector, a nipple attached to and outwardly extending from the first surface of the guard, a detachable cleaning component, having an opening and an interior surface, and a plurality of bristles attached to the interior surface and extending inwardly, where the opening is configured to receive the threaded connector, sealingly connecting the guard and the cleaning component. A method of using the pacifier comprising separating the guard from the cleaning component, inserting the nipple into the cleaning component through the opening, moving the nipple within the cleaning component, such that the bristles contact the nipple, removing the nipple from the cleaning component; and sealing the cleaning component to the guard.
    Type: Application
    Filed: January 16, 2015
    Publication date: July 21, 2016
    Inventor: Marie Bosco
  • Publication number: 20160206519
    Abstract: The invention relates to a process for preparing dental restorations, wherein a lithium silicate glass ceramic or a lithium silicate glass is used which contains at least 8.5 wt.-% transition metal oxide selected from the group consisting of oxides of yttrium, oxides of transition metals with an atomic number from 41 to 79 and mixtures of these oxides.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 21, 2016
    Inventors: Christian Ritzberger, Wolfram Höland, Marcel Schweiger, Volker Rheinberger
  • Publication number: 20160206520
    Abstract: The present disclosure provides addition-fragmentation oligomers of the general formula: The crosslinking oligomers of this disclosure provide stress relief by including labile crosslinks that can cleave and reform during the polymerization process.
    Type: Application
    Filed: September 5, 2014
    Publication date: July 21, 2016
    Inventors: Ann R. Fornof, William H. Moser, Ahmed S. Abuelyaman, Guy D. Joly, Larry R. Krepski
  • Publication number: 20160206521
    Abstract: Provided herein are a biocompatible gels such as an oral gel composition. Generally, the oral gel composition may comprise a formulation in ozonized water of a cross-linked polyacrylate polymer and a preservative and sodium hydroxide, acetic acid, and glycerol to polymerize the polyacrylate. Optionally, the oral gel composition may comprise a sweetener and/or a flavoring agent. The topical gel composition is a similar formulation in ozonized water with a cross-linked polyacrylate polymer and a preservative and sodium hydroxide, acetic acid, and hydrogen peroxide to polymerize the polyacrylate. Further provided is a method of using the gel compositions to reduce dental caries.
    Type: Application
    Filed: March 28, 2016
    Publication date: July 21, 2016
    Inventor: Arcadio Maldonado Rodriguez
  • Publication number: 20160206522
    Abstract: A novel microcapsule which is endowed for example with reduced leakage of encapsulated materials. The microcapsule contains one or more fragrances and is suitable for inclusion in non-edible consumer goods products, laundry products, personal care products and cosmetic products. The microcapsule can be obtained in an economic and efficient manner by polymerizing an emulsion so that emulsion droplets are encapsulated into a subsequently cured polymeric shell.
    Type: Application
    Filed: July 28, 2014
    Publication date: July 21, 2016
    Applicant: TAKASAGO INTERNATIONAL CORPORATION
    Inventors: Tiphaine RIBAUT, Jonathan WARR, Stuart FRASER, Olivier ANTHONY
  • Publication number: 20160206523
    Abstract: The present invention discloses an oral composition comprising a combination of salivating agents and gum sensates in an orally acceptable carrier useful in treating and/or alleviating the symptoms associated with xerostomia. Additional components common in oral compositions may also be used, in order to potentiate the effect. Such components may be chosen among humectants, mucoadhesive polymers, water retention agents, antioxidants, antimicrobials, breath fresheners.
    Type: Application
    Filed: January 21, 2015
    Publication date: July 21, 2016
    Inventors: Honorio Velasco OBIAS, Shane Christian SMITH, Thomas Karl KNOPP, Sherry Lynn McGRAW, Sarah Elizabeth TORGESON, Ryan Christopher ORR
  • Publication number: 20160206524
    Abstract: Method of manufacturing a dental bleaching device including a dental bleaching composition and a barrier layer. The bleaching composition includes a dental bleaching agent, a generally linear high molecular weight polyvinyl pyrrolidone (PVP) and/or polyethylene oxide (PEO) tissue adhesion agent that imparts adhesiveness, a rheology-modifying agent such as fumed silica or fumed alumina that reduces or eliminates stringiness otherwise caused by the high molecular weight PVP and/or PEO, and a carrier. The barrier layer may comprise a dental tray or strip. Dental treatment devices including a barrier layer and a quantity of the dental bleaching composition positioned adjacent to the barrier layer.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 21, 2016
    Inventor: Peter M. Allred
  • Publication number: 20160206525
    Abstract: An oral care composition is disclosed comprising calcium silicate and high refractive index composite particles, wherein the refractive index of the composite particles is in the range from 1.9 to 4.0, and wherein the calcium silicate and high refractive index composite particles are present at a calcium silicate to composite particles weight ratio of 1:10 to 2:1.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 21, 2016
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Xiaoke LI, Weining LIU
  • Publication number: 20160206526
    Abstract: An oral care composition is disclosed comprising calcium silicate and high refractive index particles wherein the calcium silicate and high refractive index particles are present in a relative weight ratio of 1110 to 511 and the surfaces of the high refractive index particles are substantially uncoated by calcium.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 21, 2016
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Xiaoke Li, Weining LIU, Meili ZHANG
  • Publication number: 20160206527
    Abstract: The present invention relates to a topical composition comprising uncoated, highly porous silica beads having a particle size Dv0 of greater 0.3 ?m, a Dv100 of less than 35 ?m, a Dv50 selected in the range of 8 to 15 ?m and an oil absorption capacity selected in the range of 1.2-2.5 cc/g and a metal oxide selected from microfine double coated titanium dioxide and/or microfine coated zinc oxide.
    Type: Application
    Filed: September 25, 2014
    Publication date: July 21, 2016
    Inventors: Aline HUEBER, Christine SAECKER
  • Publication number: 20160206528
    Abstract: The present invention relates to a cosmetic antiperspirant agent including a) at least one substance selected from the group of cosmetic oils which are liquid at 20° C. and 1013 hPa, odorants, and waxes, b) at least one antiperspirant aluminum salt in a total quantity of 1 to 80% by weight, based on the total weight of the cosmetic antiperspirant agent, and c) at least one compound of formula (AS-I).
    Type: Application
    Filed: March 25, 2016
    Publication date: July 21, 2016
    Applicant: Henkel AG & Co. KGaA
    Inventors: Bernhard Banowski, Christian Kropf
  • Publication number: 20160206529
    Abstract: The present invention relates to a cosmetic antiperspirant agent containing a) at least one substance selected from the group of cosmetic oils which are liquid at 20° C. and 1013 hPa, odorants, and waxes, b) at least one antiperspirant aluminum salt in a total quantity of 1 to 80% by weight, based on the total weight of the cosmetic antiperspirant agent, and c) at least one particular alpha-hydroxy acid. The addition of the at least one alpha-hydroxy acid results in effective activation of the at least one antiperspirant aluminum salt and very good stabilization of this activated state.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 21, 2016
    Applicant: Henkel AG & Co. KGaA
    Inventors: Bernhard Banowski, Christian Kropf
  • Publication number: 20160206530
    Abstract: A method of producing mixtures of interference pigments having special effects comprises mixing at least one large particle size interference pigment with at least one normal size interference pigment of predetermined colors and in proportions desired to obtain a unique effect.
    Type: Application
    Filed: March 28, 2016
    Publication date: July 21, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Qinyun PENG, Philip Linz
  • Publication number: 20160206531
    Abstract: The present invention relates to a composition in the form of an oil-in-water emulsion, comprising, in a physiologically acceptable medium: a) at least one aqueous phase; and b) at least one oily phase comprising at least one apolar non-volatile hydrocarbon-based oil and at least one pasty apolar lipophilic hydrocarbon-based compound; and c) at least one hydrophilic gelling polysaccharide; and d) at least one mixture of emulsifying nonionic surfactants comprising (i) at least one fatty acid ester of polyol and (ii) at least one polyalkylene glycol ester. The present invention also relates to a cosmetic care process for moisturizing a human keratin material, in particular the skin, characterized in that it comprises the application to the surface of the said keratin material of a composition as defined previously.
    Type: Application
    Filed: August 21, 2014
    Publication date: July 21, 2016
    Inventors: Magali Ravaud, Matthieu Cassier
  • Publication number: 20160206532
    Abstract: Disclosed is a hair conditioning composition comprising: a cationic surfactant; a high melting point fatty compound having a melting point of 25° C. or higher; a material having a refractive index of from about 1.30 to about 1.70; and an aqueous carrier, wherein a composition has a transmittance of at least about 0.5%. The composition is further specified by either: (i) the material is a polyol having at least 3 hydroxyl groups and the polyol is contained at a level of above 30% to about 80% by weight of the composition; or (ii) the cationic surfactant is a salt of a mono-long alkyl amine and an acid. The compositions provides both translucent appearance and conditioning benefits, especially conditioning benefit on wet hair when used as a rinse-off conditioner and/or spreadability on hair.
    Type: Application
    Filed: January 14, 2016
    Publication date: July 21, 2016
    Inventors: Cedric Kofi Aurelien CALLENS, TianYong LIM, Toshiyuki IWATA
  • Publication number: 20160206533
    Abstract: Disclosed is a hair conditioning composition comprising: a cationic surfactant; a high melting point fatty compound having a melting point of 25° C. or higher; a material having a refractive index of from about 1.30 to about 1.70; and an aqueous carrier, wherein a composition has a transmittance of at least about 0.5%. The composition is further specified by either: (i) the material is a polyol having at least 3 hydroxyl groups and the polyol is contained at a level of above 30% to about 80% by weight of the composition; or (ii) the cationic surfactant is a salt of a mono-long alkyl amine and an acid. The compositions provides both translucent appearance and conditioning benefits, especially conditioning benefit on wet hair when used as a rinse-off conditioner and/or spreadability on hair.
    Type: Application
    Filed: January 14, 2016
    Publication date: July 21, 2016
    Inventors: Cedric Kofi Aurelien CALLENS, TianYong LIM, Toshiyuki IWATA
  • Publication number: 20160206534
    Abstract: The invention relates to an antiperspirant cosmetic agent, having a) at least one substance, selected from the group of cosmetic oils that are liquid at 20° C. and 1,013 hPa, aromatic substances, and waxes, b) at least one antiperspirant aluminum salt in a total amount of 1 to 80 wt %, with respect to the total weight of the antiperspirant cosmetic agent, and c) at least one compound of formula (PC-I).
    Type: Application
    Filed: March 24, 2016
    Publication date: July 21, 2016
    Applicant: Henkel AG & Co. KGaA
    Inventor: Bernhard Banowski
  • Publication number: 20160206535
    Abstract: Formulations, kits, and methods for rebuilding the disulfide bonds in keratin found in hair, skin, or nails. Hair that is damaged due to a hair coloring treatment and/or other reducing treatment, such as during a permanent wave, can be treated with the formulations containing one or more active agents. The formulations may be applied subsequent to a hair coloring treatment or simultaneously with a hair coloring treatment. Use of the active agent formulations during a permanent wave treatment prevents the reversion of the hair to its previous state, for at least one week, preferably at least three months, more preferably at least one year, most preferably greater than one year, after one or more than one application of the formulation. Application of the active agent formulation to skin or nails can help repair damaged disulfide bonds due to natural wear and tear or natural aging.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 21, 2016
    Inventors: Eric D. Pressly, Craig J. Hawker
  • Publication number: 20160206536
    Abstract: A method of improving the appearance of skin, involves topically administering to a subject in need thereof a botanical antioxidant composition having a botanical antioxidant extract blend with: (a) at least one hydroxycinnamic acid, and (b) a camellia sinesis, vitis vinifera, euterpe oleracea, curcuma longa, and/or theobroma cacao extract, wherein the composition is in cream, lotion, solution, serum, anhydrous preparation, emulsion, microemulsion, multiple emulsion, gel, solid stick, ointment, dry powder, spray, or aerosol form.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 21, 2016
    Inventors: Joseph Abernathy LEWIS, II, Joseph C. DINARDO
  • Publication number: 20160206537
    Abstract: Sustainable, free-flowing, cold-dispersible pearlescent concentrates are made without using any controversial or known toxic substance is disclosed herein. The pearlizing concentrates of the instant invention are free of alkyl sulphates/alkyl ether sulphates, alkanol amides, alkylamidopropyl betaines, and esters of ethylene glycol. The pearly concentrates of the present invention employ ‘super-mild’ surfactants to disperse vegetable plant derived 1,3-proane diol stearates. Also, these concentrates are preserved without any controversial antimicrobials such as parabens, isothiazolinones and formaldehyde releasers.
    Type: Application
    Filed: March 26, 2014
    Publication date: July 21, 2016
    Applicant: GALAXY SURFACTANTS, LTD.
    Inventors: Nirmal KOSHTI, Pritesh Rajaram MHATRE, MilindKumar Suresh KALEKAR, Pooja Vaidya KSHIRSAGAR
  • Publication number: 20160206538
    Abstract: Provided is a topical formulation comprising (1) three or more of the following four components a through d, or (2) component c and one or more of components a, b or d: (a) a skin barrier repair formulation comprising fatty acid, bilayer-stabilizing steroid, and complex lipid (CL), wherein the weight ratio of CL to steroid is from about 1.5:1 to about 8:1, and the weight ration of CL to FA is from about 4:1 to about 1:1, the lipids present in an amount from about 3% wt. to about 10% wt.; (b) a natural moisturizer formulation, wherein the natural moisturizers are urea, urocanic acid, pyrrolidone-5-carboxylic acid, lactic acid or free amino acid; (c) one or more retinoids in an amount from about 0.01% wt. to about 10% wt.; or (d) taurine in an amount from about 0.1% wt. to about 5% wt.
    Type: Application
    Filed: December 22, 2015
    Publication date: July 21, 2016
    Inventors: Thomas Sköld, Georgia Levis, Michael J. Burns
  • Publication number: 20160206539
    Abstract: The present invention relates to a composition for care of skin and scalp. The invention ensures lightening of skin using and provides anti-dandruff benefits to the scalp. This has been possible by way of including Granilin in a composition to be applied topically on these surfaces.
    Type: Application
    Filed: September 4, 2014
    Publication date: July 21, 2016
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Anita DAMODARAN, Aryasekhar SANYAL
  • Publication number: 20160206540
    Abstract: The present disclosure relates to compounds, cosmetic or dermopharmaceutical compositions comprising the same, and methods for using the compounds or compositions for treating, protecting, and/or improving the condition and/or aesthetic appearance of skin, for example, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, or improving the appearance of fine lines and/or or wrinkles of skin comprising application of the compounds or compositions disclosed.
    Type: Application
    Filed: August 20, 2015
    Publication date: July 21, 2016
    Inventors: John Hood, Sunil Kumar KC, Osman Kibar, Charlene F. Barroga
  • Publication number: 20160206541
    Abstract: The invention relates to an antiperspirant cosmetic agent, including a) at least one substance, selected form the group of cosmetic oils that are liquid at 20° C. and 1.013 hPa, aromatic substances, and waxes, b) at least one antiperspirant aluminum salt in a total amount of 0.
    Type: Application
    Filed: March 25, 2016
    Publication date: July 21, 2016
    Applicant: Henkel AG & Co. KGaA
    Inventors: Bernhard Banowski, Marcus Claas
  • Publication number: 20160206542
    Abstract: The invention concerns topical compositions based on retinaldehyde, glycylglycine oleamide and, if necessary, delta-tocopheryl-glucopyranoside, and their use in cosmetology and dermatology to combat skin ageing and more particularly light-induced skin ageing.
    Type: Application
    Filed: June 3, 2014
    Publication date: July 21, 2016
    Applicant: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Daniel BACQUEVILLE, Patrick BOGDANOWICZ, Jean-Hilaire SAURAT, Olivier SORG
  • Publication number: 20160206543
    Abstract: Methods and compositions are provided for mitigating the irritation of mammalian skin cells, protecting cell viability and/or enhancing cell-cell junction, thus improving skin barrier function. The compositions contain combinations of acetyl hexapeptides and a cosmetically and/or pharmaceutically acceptable carrier. Carriers that lend a liquid crystalline aspect to the compositions are beneficial.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 21, 2016
    Inventors: Jessica R. Tittl, Christopher A. Wolf
  • Publication number: 20160206544
    Abstract: The present invention generally relates to deuterium-enriched hyaluronan, d-HA, compositions containing the same, methods of using the same, and methods for making the same.
    Type: Application
    Filed: November 15, 2015
    Publication date: July 21, 2016
    Inventor: Glenn Prestwich
  • Publication number: 20160206545
    Abstract: The invention relates to an emulsifier-free, skin conditioning cosmetic or dermatological preparation which contains peeling active ingredients.
    Type: Application
    Filed: August 25, 2014
    Publication date: July 21, 2016
    Inventor: Horst ARGEMBEAUX
  • Publication number: 20160206546
    Abstract: Composition comprising an aminosilicone, a cationic surfactant, an associative polymer and a thickening agent The present invention relates to a composition for treating keratin fibres, in particular human keratin fibres such as the hair, comprising (i) one or more amino silicones, (ii) one or more cationic surfactants different from (i), (iii) one or more associative polymers and (iv) one or more thickening agents different from (iii). The invention also concerns a process for treating keratin fibres, in particular human keratin fibres such as the hair, and a use for hair care employing the said composition.
    Type: Application
    Filed: August 1, 2013
    Publication date: July 21, 2016
    Inventors: Pedro Aprigliano FERNANDES, Fabiana PINHO
  • Publication number: 20160206547
    Abstract: The present invention relates to a cosmetic composition, especially a haircare composition for conditioning the hair, which comprises an amino silicone, a cationic surfactant, a fatty alcohol comprising 8 to 30 carbon atoms, and a hydrocarbon-based oil. The invention also relates to a treatment process for keratin substances, in particular for conditioning hair, implementing said cosmetic composition.
    Type: Application
    Filed: September 2, 2013
    Publication date: July 21, 2016
    Applicant: L'OREAL
    Inventors: Diego ALVES, Alice Matos XAVIER
  • Publication number: 20160206548
    Abstract: A pre-moistened wipe is provided and comprises a substrate, and a composition comprising between about 80% to about 100% by volume of coconut oil, wherein the composition is releasably contacting the substrate. The substrate may be a fibrous material, including a nonwoven. In one aspect the composition comprises about 95% by volume coconut oil, about 1% by volume holy basil, about 1% by volume avocado oil, about 1% by volume aloe vera oil, about 1% by volume turmeric oil, and about 1% by volume neem oil. A method of delivering coconut oil to the skin is also provided and comprises a step of contacting skin with the wipe.
    Type: Application
    Filed: January 20, 2016
    Publication date: July 21, 2016
    Inventors: Eleanor Ismail, Adam Ismail, Srinivas Naga Chadaram, Sharif Razzaque
  • Publication number: 20160206549
    Abstract: A botanical antioxidant composition has a botanical antioxidant extract blend with at least 50 wt. % of the blend having one or more hydroxycinnamic acid, and: a first component comprising a camellia sinesis extract, a vitis vinifera extract, a euterpe oleracea extract, a curcuma longa extract, or a theobroma cacao extract; and a second component, different from the first component, comprising the camellia sinesis extract, the vitis vinifera extract, the euterpe oleracea extract, the curcuma longa extract, or the theobroma cacao extract; wherein the composition is a cosmetic or dermatological formulation in a cream, lotion, solution, serum, anhydrous preparation, emulsion, microemulsion, multiple emulsion, gel, solid stick, ointment, dry powder, spray, or aerosol form.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 21, 2016
    Inventors: Joseph Abernathy LEWIS, II, Joseph C. DINARDO
  • Publication number: 20160206550
    Abstract: The present disclosure relates to a conditioned medium (CM) enriched with bioactive factor, its composition and the method of producing the CM. The method of obtaining the desired quantity of bioactive factors in conditioned medium comprises of pooling bone marrow derived mesenchymal stromal/stem cells, culturing the pooled cell and subjecting the cell culture to a cell feeding schedule at specified confluency and collecting the potent conditioned medium rich in bioactive factors at specific passage/time period. The method further aims at maximizing the probability of generating a conditioned medium with reduced biological variability and comprising large number of bioactive factors having specific biological function/property. The disclosure also relates to composition and formulation of the conditioned medium and their use in cosmetic and therapeutic areas.
    Type: Application
    Filed: June 18, 2014
    Publication date: July 21, 2016
    Applicant: STEMPEUTICS RESEARCH PVT. LTD.
    Inventors: Sudha BALASUBRAMANIAN, Swathi SUNDAR RAJ, Charan THEJ, Ramesh RAMCHANDRA BHONDE, Raviraja NEELAVAR SEETHARAM, Anish SEN MAJUMDAR
  • Publication number: 20160206551
    Abstract: This application relates to cosmetic methods for improving skin conditions. The methods generally include the administration of platelet-rich plasma and cultured autologous cells to a subject after a micro-needling procedure has been performed. The platelet-rich plasma and autologous cells can be topically applied to the skin surface or injected into the dermis or subcutaneous tissue. The methods may be used to improve conditions such as acne scars, traumatic scars, hyperpigmentation, fine lines, wrinkles, stretch marks, and hair loss.
    Type: Application
    Filed: January 15, 2015
    Publication date: July 21, 2016
    Inventor: William K. BOSS, JR.
  • Publication number: 20160206552
    Abstract: The invention provides a composition suitable for topical skin application comprising isolated queen bee venom. The queen bee venom has been found to be significantly superior for treating skin conditions relative to the normal bee venom. Therefore the invention also provides a method of treatment or prevention of a skin condition, comprising the topical application of the composition onto the skin of a subject afflicted with the skin condition, or at risk of being afflicted with the skin condition. The skin condition could be skin ageing, elastosis, laxity (sagging), rhytids (wrinkles), skin infection, skin damage, skin burn, pain, and muscle tightness, or combinations thereof.
    Type: Application
    Filed: August 23, 2013
    Publication date: July 21, 2016
    Inventor: Deborah MITCHELL
  • Publication number: 20160206553
    Abstract: A composition for topical application characterized in that it includes, in a hydrogel base, vanillyl butyl ether and menthol. The composition described herein produces an ordered development of cold and warm sensations, obtaining effects that are particularly useful in the treatment of painful disorders of neurological and/or muscular origin. The composition has further moisturizing and soothing effects that concur to an effect that is also curative, i.e., not simply symptomatic, of rheumatic and muscular pain, trauma and bruises. The composition is compatible with each administration form, being preferably and advantageously formulated as a plaster.
    Type: Application
    Filed: September 17, 2014
    Publication date: July 21, 2016
    Applicant: ALTERGON S.A.
    Inventors: Maurizio PAGLIUCA, Antonio MILEO, Danilo TRUPPA, Giuseppe BERGAMO
  • Publication number: 20160206554
    Abstract: Methods and compositions for preventing and treating the damaged and/or degenerating CNS experiencing loss or death of CNS cells. Various embodiments of the invention transport a therapeutically effective amount of, inter alfa at least one therapeutic cell to the CNS by intranasal application to the upper-third of the nasal cavity, thereby bypassing the blood-brain barrier. A pharmaceutical composition according to the invention may comprise at least one therapeutic cell, at least one delivery-enhancement agent, at least one antibiotic, at least one regulatory factor and/or at least one immunosuppressive agent, wherein the composition is delivered to the upper-third of the nasal cavity. The therapeutic cells, once delivered to the CNS, migrate preferentially to the area of damage or degeneration or injury.
    Type: Application
    Filed: March 28, 2016
    Publication date: July 21, 2016
    Inventors: William H. Frey, II, Lusine Danielyan, Christoph H. Gleiter
  • Publication number: 20160206555
    Abstract: The invention relates to a method of inducing emesis in animals, particularly companion animals such as dogs and cats, in situations where vomiting is desired. The method comprises administering an eye drop composition comprising a selective D2 family dopamine agonist as an active ingredient to the eye of the animal to induce emesis. The method and the composition are useful in situations involving ingestion of a potentially toxic substance or foreign body by the animal.
    Type: Application
    Filed: September 29, 2014
    Publication date: July 21, 2016
    Applicant: ORION CORPORATION
    Inventors: Jouko LEVIJOKI, Lasse SALORANTA, Johanna KOKKONEN
  • Publication number: 20160206556
    Abstract: Provided is a biodegradable ocular implant for sustained drug delivery, including a first layer comprising a first biodegradable polymer, wherein the first layer contains a drug dispersed or dissolved therein. A multi-layered biodegradable ocular implant is also disclosed.
    Type: Application
    Filed: September 23, 2015
    Publication date: July 21, 2016
    Inventors: Subramanian VENKATRAMAN, Yin Chiang Freddy BOEY, Tina WONG, Jodhbir METHA
  • Publication number: 20160206557
    Abstract: The present invention relates to a solid pharmaceutical dosage forms and methods for preparing the solid pharmaceutical dosage form that contains fingolimod or its pharmaceutically acceptable salts, conjugates or complexes thereof. The solid pharmaceutical dosage forms may rapidly disintegrates in a patient's oral cavity.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 21, 2016
    Inventor: Fangyu Liu
  • Publication number: 20160206558
    Abstract: Compositions and methods for the treatment of pain in a mammal are described. More specifically, a dosage form designed for release of acetaminophen and an opioid is described, wherein the dosage form provides delivery of the drugs to the upper gastrointestinal tract (“GI”) of a mammal for an extended period of time.
    Type: Application
    Filed: March 30, 2016
    Publication date: July 21, 2016
    Inventors: Chien-Hsuan Han, Sui Yuen Eddie Hou, Monica L. Reid
  • Publication number: 20160206559
    Abstract: This invention provides a dry powder inhaler comprising: a dry powder medicament comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of fluticasone propionate per actuation is less than 100 ?g; and wherein the dose provides a baseline-adjusted FEV1 in a patient of more than 150 mL within 30 minutes of receiving the dose. A method of treating a patient includes administering to a patient a dry powder medicament having fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of fluticasone propionate per actuation is less than 100 ?g; and wherein the dose provides a baseline-adjusted FEV1 in a patient of more than 150 mL within 30 minutes of receiving the dose.
    Type: Application
    Filed: January 20, 2016
    Publication date: July 21, 2016
    Applicant: Teva Branded Pharmaceutical Products R&D, Inc.
    Inventors: Mukul DALVI, Seah Kee TEE
  • Publication number: 20160206560
    Abstract: Non-aqueous, ethanol-free taxane formulations are provided. Formulations of embodiments of the invention include a taxane, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid component, wherein the organic acid component is soluble in the non-aqueous solvent and the amount by weight of non-ionic surfactant is equal to or greater than the amount by weight of non-aqueous solvent. Also provided are methods of using the formulations, as well as kits that include the formulations. Non-aqueous, ethanol-free docetaxel formulations are provided. Formulations of embodiments of the invention include docetaxel, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid which is soluble in the non-aqueous solvent and is substantially free of any conjugate base. Also provided are methods of using the formulations, as well as kits that include the formulations.
    Type: Application
    Filed: March 10, 2016
    Publication date: July 21, 2016
    Applicant: Teikoku Pharma USA, Inc.
    Inventor: Kiichiro Nabeta
  • Publication number: 20160206561
    Abstract: A complex coacervate delivery system is provided which encapsulates lipophilic nutrients such as, for example, fish oils high in omega-3 fatty acids. The complex coacervate delivery system protects the lipophilic nutrient from degradation, e.g., oxidation and hydrolysis, and also reduces or eliminates the unpleasant taste and odor of the lipophilic nutrient. The complex coacervate delivery system upon ingestion is operative to substantially release the lipophilic nutrient in the lower gastrointestinal tract in a pH-controlled manner. The complex coacervate delivery system may be included in a food or beverage product having a pH value within the range of about 1.5 to about 5.0.
    Type: Application
    Filed: November 17, 2015
    Publication date: July 21, 2016
    Inventors: Daniel S. KOHANE, Yoon YEO, Peter GIVEN, Robert S. LANGER